Fri, Mar 01, 2013 09:05 - VentriPoint Diagnostics Ltd. (VPTDF: OTC Link) released their Home Country News Release concerning VentriPoint Receives US-FDA Acceptance of 510 (k) Submission for Pulmonary Arterial Hypertension. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=100158.
VentriPoint Diagnostics (PK) (USOTC:VPTDF)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more VentriPoint Diagnostics (PK) Charts.
VentriPoint Diagnostics (PK) (USOTC:VPTDF)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more VentriPoint Diagnostics (PK) Charts.